FEATURES OF T-HELPER IMMUNE RESPONSE IN YOUNG CHILDREN WITH CONGENITAL CLEFT LIP AND PALATE IN ACUTE PNEUMONIA
Abstract
А significant proportion of children with repeated acute respiratory infections (ARI) and recurrent chronic diseases of the respiratory tract and ENT organs are carriers of co-infections. Objective: to study the synthesis of key cytokines Th-1/ Th-2/ Th-17 types of immune responses in children with congenital cleft lip and palate in acute pneumonia. Material and methods: the present study included 38 children with an established diagnosis of acute pneumonia (18 infants with CCLP and 20 children without CCLP formed the comparison group) and 16 practically healthy children formed the control group. The concentration of interleukins and interferon-gamma in the blood serum was determined by solid-phase enzyme immunoassay using test systems of Vector-Best JSC (Novosibirsk, Russia). Results: It was found that in the groups of children with pneumonia, both with cleft lip and palate and without congenital pathology, there was a significant increase in the content of IL-17A, IL-4 in the peripheral blood and a deficiency of IFN-γ in children of the first year of life, which indicates an imbalance in the immune response that can affect the course and severity of the infection. Conclusions: The study of the cytokine profile in a comparative aspect revealed hypersecretion of key mediators of the Th2 and Th17 immune response (IL-4 and IL-17A) and a deficiency in the synthesis of the key antiviral cytokine Th1 immune response (IFN γ) in all groups of children with pneumonia.
About the Authors
List of references
Musaxodjayeva D.A., Inoyatov A.Sh., Sharopov S.G. Analysis of modern views on risk factors for development of congenital defects of the chelyustical and facial region. News in Medicine, (Tashkent) 2019;
Nesterova I.V., Kovaleva S.V., Chudilova G.A., Malinovskaya V.V. Interferon and immunotherapy in rehabilitation of immunocompromised children with recurrent respiratory infections. In the book: Immunoterapiya v praktike ENT-vracha i terapevta. A.S. Simbirsev, G.V. Lavrenova (eds.). Sankt-Peterburg: Dialog. 2018: 167–89.
Karimjonov I.A., Madraximov P.M. Characteristics of immunological disorders in acute pneumonia and frequently sick children. // Re-health journal-2021/-1(9).-126-129.
Shkarin V.V., Sergeyeva A.V. Epidemiological and clinical features of chronic respiratory infections in children. Children's infections. 2017; 1: DOI: https://doi.org/10.22627/2072-8107-2017-16-1-51-56
Afzali B., Lombardi G., Lecher R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. J. Clinical and Experimental Immunology, 2017, Vol. 148, pp. 32-46 DOI: https://doi.org/10.1111/j.1365-2249.2007.03356.x
Bulat-Kardum LJ, Etokebe GE, Lederer P, Balen S, Dembic Z. Genetic polymorphisms in the toll-like receptor 10, interleukin (IL) 17A and IL17F genes differently affect the risk for tuberculosis in the Croatian population. Scand J Immunol 2017; 82:63–69 DOI: https://doi.org/10.1111/sji.12300
Burke JD, Young HA. IFN-γ: a cytokine at the right time, is in the right place. Semin Immunol. 2019; 43:1–8 DOI: https://doi.org/10.1016/j.smim.2019.05.002
Cătană CS, Neagoe IB, Cozma V, Magdaş C, Tăbăran F, Dumitraşcu DL. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2018; 21:5823–5830 DOI: https://doi.org/10.3748/wjg.v21.i19.5823
Goepfert, A., Lehmann, S., Blank, J., Kolbinger, F. & Rondeau, J. M. Structural analysis reveals that the cytokine IL-17F forms a homodimeric complex with receptor IL-17RC to drive IL-17RA-independent signaling. Immunity 52, 499–512.e5 (2020) DOI: https://doi.org/10.1016/j.immuni.2020.02.004
SC Wilson, NA Caveney, M Yen, C Pollmann, X Xiang. Organizing structural principles of the IL-17 ligand–receptor axis. Nature 2022:556–567. DOI: https://doi.org/10.1038/s41586-022-05116-y
Ivashkiv LB. IFNγ: signaling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18(9):545–58 DOI: https://doi.org/10.1038/s41577-018-0029-z
Mendoza JL, Escalante NK, Jude KM, Bellon JS, Su L, Horton TM, et al. Structure of the IFNγ receptor complex guides design of biased agonists. Nature. 2019; 567:56–60. DOI: https://doi.org/10.1038/s41586-019-0988-7
Zwicky, P., Unger, S. & Becher, B. Targeting interleukin-17 in chronic inflammatory disease: a clinical perspective. J. Exp. Med. 217, 1–16 (2020). DOI: https://doi.org/10.1084/jem.20191123
Gunjan Kak, Mohsin Raza, Brijendra K Tiwari. Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases. BioMol Concepts 2018; 9: 64–79. DOI: https://doi.org/10.1515/bmc-2018-0007
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
